TNXP

Conviction 34HealthcareScan · Fri, Jun 26, 2026

Bullish engulfing

TNXP$13.19+10.10%

ResistanceSupportVol 14Insider buy

Vol MA14 709.42K

Mar 27Apr 15May 4May 20Jun 9Jun 26

Tonix Pharmaceuticals Holding Corp.PHARMACEUTICAL PREPARATIONSwww.tonixpharma.com ↗

Price13.19

Change+10.10%

Gap-0.92%

Rel volume3.81×

Avg volume642.63K

Avg $ vol7.62M

SMA 2011.78

SMA 5012.82

SMA 20016.46

Price vs 50+2.88%

Price vs 200-19.84%

MA stackmixed

50/200 cross—

Supertrenddown · 13.66

RSI (14)58

MACD hist0.21

MACD crossbull · 6d

Stoch %K / %D89 / 72

ADX (14)13

+DI / −DI27 / 17

RSI divergence—

MACD divergence—

ATR %+7.66%

ADR %7.84%

52w high61.57

52w low10.65

From 52w high-78.58%

Above 52w low+23.85%

New 52w highNo

SqueezeOn · 5d

Bollinger width18.79%

%B1.14

Donchian pos89.27%

Donchian high13.57

Donchian low10.03

AVWAP (52w high)22.57

vs AVWAP high-41.55%

AVWAP (52w low)11.97

vs AVWAP low+10.17%

OBV trendFlat

Chaikin MF (20)-0.06

Today vs 20d3.81×

Avg vol (14d)709.42K

Avg vol (20d)642.63K

Avg $ vol (20d)7.62M

Market cap—

RS 3m (vs SPY)-31.93%

RS 6m (vs SPY)-37.04%

RS line new highNo

Trend template1/8

Technical rank39.9

1 week+9.83%

1 month+8.56%

3 months-4.07%

6 months-21.39%

1 year-61.19%

YTD-20.30%

P/E-1.54

P/B0.84

P/S14.55

P/FCF-1.85

EPS-14.57

Div yield—

ROE-54.60%

ROA-48.09%

Debt/Eq0.03

Current6.99

EV/EBITDA-0.10

Gross margin—

Net margin-946.22%

Rev growth29.85%

EPS growth4.63%

Price target37.67

Target upside214.97%

Analyst ratingBuy

Institutional34.72%

Ent. value12.67M

Revenue6.88M

Net income-40.19M

Gross profit—

Free cash flow-103.21M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out15.94M

Employees142

ListedFri, Feb 13, 2009

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction34 / 100

Pattern quality—

Tech rank39.9 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBullish engulfing

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in TNXP

All disclosures →

No recent disclosed trades by Congress in TNXP. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in TNXP · 9 buys

Insider	Side	Shares	Value	Traded	Filed
LEDERMAN SETH Chief Executive Officer · Common Stock, $0.001 par value · 2026-06-09	Other	—	—	2026-06-09	2026-06-09
LEDERMAN SETH Chief Executive Officer · Common Stock, $0.001 par value · 2026-06-09	Buy	5K	$59K	2026-06-09	2026-06-09
Stillwell Richard Newcomb Director · Common Stock, $0.001 par value · 2026-06-08	Buy	5K	$58K	2026-06-08	2026-06-09
Stillwell Richard Newcomb Director · Stock Option · 2026-05-12	Grant	22.7K	$0	2026-05-12	2026-05-14
BAGGER RICHARD H Director · Stock Option · 2026-05-12	Grant	22.7K	$0	2026-05-12	2026-05-14
Hunter James Randolph Jr Director · Stock Option · 2026-05-12	Grant	22.7K	$0	2026-05-12	2026-05-14
Treco James Director · Stock Option · 2026-05-12	Grant	22.7K	$0	2026-05-12	2026-05-14
GRANGE DAVID L Director · Stock Option · 2026-05-12	Grant	22.7K	$0	2026-05-12	2026-05-14
Bell Margaret Smith Director · Stock Option · 2026-05-12	Grant	22.7K	$0	2026-05-12	2026-05-14
Taylor Carolyn E. Director · Stock Option · 2026-05-12	Grant	22.7K	$0	2026-05-12	2026-05-14

SEC filings

EDGAR filings in TNXP · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.